Firms Fight For Lead Role In Lion Biotech Investor Case
A battle broke out in California federal court Tuesday over which firm will be named lead counsel in a proposed class action accusing Lion Biotechnologies of artificially inflating its stock price...To view the full article, register now.
Already a subscriber? Click here to view full article